$TMBR Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Timber Pharmaceuticals, Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in Timber Pharmaceuticals, Inc.. Get notifications about new insider transactions in Timber Pharmaceuticals, Inc. for free.

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
May 13 2021	TMBR	Timber Pharmaceuti ...	Mendelsohn Alan	Chief Medical Offic ...	Buy	P	2.17	1,988	4,314	1,988	0 to 2 K
Sep 16 2020	BPMX	Timber Pharmaceuti ...	TardiMed Sciences LLC	10% Owner	Sell	S	1.03	100,694	103,695	5,437,517	5.5 M to 5.4 M (-1.82 %)
Sep 16 2020	BPMX	Timber Pharmaceuti ...	TardiMed Sciences LLC	10% Owner	Sell	S	1.03	87,060	89,550	5,538,211	5.6 M to 5.5 M (-1.55 %)
Sep 16 2020	BPMX	Timber Pharmaceuti ...	TardiMed Sciences LLC	10% Owner	Sell	S	1.03	455	469	5,625,271	5.6 M to 5.6 M (-0.01 %)
Sep 14 2020	BPMX	Timber Pharmaceuti ...	TardiMed Sciences LLC	10% Owner	Sell	S	1.03	7,483	7,710	5,625,726	5.6 M to 5.6 M (-0.13 %)
Sep 14 2020	BPMX	Timber Pharmaceuti ...	TardiMed Sciences LLC	10% Owner	Sell	S	1.04	32,943	34,379	5,633,209	5.7 M to 5.6 M (-0.58 %)
Jun 09 2020	BPMX	Timber Pharmaceuti ...	BROENNIMAN LINDA A	Director	Option Exercise	A	2.87	24,270	69,655	24,270
Jun 09 2020	BPMX	Timber Pharmaceuti ...	Stocum Michael	Director	Option Exercise	A	2.87	24,270	69,655	24,270
Jun 09 2020	BPMX	Timber Pharmaceuti ...	Lucchese Joseph	Executive VP & CFO	Option Exercise	A	2.87	97,083	278,628	97,083
Jun 09 2020	BPMX	Timber Pharmaceuti ...	Sitar Edward J	Director	Option Exercise	A	2.87	24,270	69,655	24,270
Jun 09 2020	BPMX	Timber Pharmaceuti ...	Pirozzi Gianluca	Director	Option Exercise	A	2.87	24,270	69,655	24,270
Jun 09 2020	BPMX	Timber Pharmaceuti ...	Bragg Kimberly	Controller	Option Exercise	A	2.87	38,833	111,451	38,833
May 20 2020	BPMX	Timber Pharmaceuti ...	TardiMed Sciences LLC	10% Owner	Option Exercise	J	0.00	1,821	0	1,821
May 20 2020	BPMX	Timber Pharmaceuti ...	TardiMed Sciences LLC	10% Owner	Buy	J	0.00	5,666,152	0	5,666,152	0 to 5.7 M
May 20 2020	BPMX	Timber Pharmaceuti ...	Rome Zachary	Executive VP, COO a ...	Option Exercise	A	0.01	132,209	1,322	132,209
May 20 2020	BPMX	Timber Pharmaceuti ...	Koconis John	Chief Executive Off ...	Option Exercise	A	0.01	209,646	2,096	209,646
May 20 2020	BPMX	Timber Pharmaceuti ...	Tavakkol Amir	Chief Scientific Of ...	Option Exercise	A	0.01	8,184	82	8,184
Feb 12 2020	BPMX	BioPharmX Corp	Timber Pharmaceuticals LLC	10% Owner	Sell	S	0.01	55,008	550	2,200,328	2.3 M to 2.2 M (-2.44 %)
Feb 12 2020	BPMX	BioPharmX Corp	Timber Pharmaceuticals LLC	10% Owner	Buy	X	0.01	2,255,336	22,553	2,255,336	0 to 2.3 M
Feb 12 2020	BPMX	BioPharmX Corp	TardiMed Sciences LLC	10% Owner	Option Exercise	X	0.01	2,225,336	22,253	0
Feb 12 2020	BPMX	BioPharmX Corp	TardiMed Sciences LLC	10% Owner	Sell	S	0.01	55,008	550	2,200,328	2.3 M to 2.2 M (-2.44 %)
Feb 12 2020	BPMX	BioPharmX Corp	TardiMed Sciences LLC	10% Owner	Buy	X	0.01	2,255,336	22,553	2,255,336	0 to 2.3 M
Jul 18 2019	BPMX	BioPharmX Corp	Bosacki Steven	Chief Operating Off ...	Option Exercise	A	0.44	91,000	40,040	91,000
Jun 27 2019	BPMX	BioPharmX Corp	Vivo Capital VIII, LLC	10% Owner	Sell	S	1.02	327,870	334,427	317,270	645.1 K to 317.3 K (-50.82 %)
Jun 14 2019	BPMX	BioPharmX Corp	Goto Joyce		Option Exercise	A	0.84	70,000	58,800	70,000
Jun 14 2019	BPMX	BioPharmX Corp	Chan Kin Foong	EVP of R&D	Option Exercise	A	0.84	77,100	64,764	77,100
Jun 14 2019	BPMX	BioPharmX Corp	Tierney David S	Pres and CEO	Option Exercise	A	0.84	360,000	302,400	360,000
Jun 14 2019	BPMX	BioPharmX Corp	Plott Ronald Todd	Director	Option Exercise	A	0.84	32,700	27,468	32,700
Jun 14 2019	BPMX	BioPharmX Corp	Morlock Stephen	Director	Option Exercise	A	0.84	32,700	27,468	32,700
Jun 14 2019	BPMX	BioPharmX Corp	Hubbard Michael	Director	Option Exercise	A	0.84	32,700	27,468	32,700
Feb 21 2019	TPND	BioPharmX Corp	Plott Ronald Todd	Director	Option Exercise	A	0.20	51,000	10,200	418,000
Feb 21 2019	TPND	BioPharmX Corp	Plott Ronald Todd	Director	Option Exercise	A	0.20	34,000	6,800	367,000
Feb 21 2019	TPND	BioPharmX Corp	Plott Ronald Todd	Director	Option Exercise	A	0.11	200,000	22,000	333,000
Feb 21 2019	TPND	BioPharmX Corp	Plott Ronald Todd	Director	Option Exercise	A	0.11	133,000	14,630	133,000
Jan 25 2019	TPND	BioPharmX Corp	Krammer Anja B	Director	Sell	S	0.11	115,874	12,746	1,884,126	2 M to 1.9 M (-5.79 %)
Oct 31 2018	TPND	BioPharmX Corp	Goto Joyce		Option Exercise	A	0.20	77,000	15,400	77,000
Oct 31 2018	TPND	BioPharmX Corp	Goto Joyce		Option Exercise	A	0.17	470,000	79,900	470,000
Oct 22 2018	TPND	BioPharmX Corp	Morlock Stephen	Director	Sell	S	0.18	251,071	45,193	0	251.1 K to 0 (-100.00 %)
Oct 22 2018	TPND	BioPharmX Corp	Morlock Stephen	Director	Sell	S	0.18	220,766	39,738	0	220.8 K to 0 (-100.00 %)
Oct 22 2018	TPND	BioPharmX Corp	Morlock Stephen	Director	Sell	S	0.18	214,091	38,536	220,766	434.9 K to 220.8 K (-49.23 %)
Oct 22 2018	TPND	BioPharmX Corp	Morlock Stephen	Director	Sell	S	0.19	439,099	83,429	434,857	874 K to 434.9 K (-50.24 %)
Oct 12 2018	TPND	BioPharmX Corp	Krammer Anja B	Director	Sell	S	0.19	297,500	56,525	2,000,000	2.3 M to 2 M (-12.95 %)
Oct 12 2018	TPND	BioPharmX Corp	Krammer Anja B	Director	Sell	S	0.19	100,000	19,000	2,297,500	2.4 M to 2.3 M (-4.17 %)
Oct 12 2018	TPND	BioPharmX Corp	Krammer Anja B	Director	Sell	S	0.19	102,500	19,475	2,397,500	2.5 M to 2.4 M (-4.10 %)
Oct 12 2018	TPND	BioPharmX Corp	Krammer Anja B	Director	Sell	S	0.19	297,500	56,525	2,000,000	2.3 M to 2 M (-12.95 %)
Oct 12 2018	TPND	BioPharmX Corp	Krammer Anja B	Director	Sell	S	0.19	100,000	19,000	2,297,500	2.4 M to 2.3 M (-4.17 %)
Oct 12 2018	TPND	BioPharmX Corp	Krammer Anja B	Director	Sell	S	0.19	102,500	19,475	2,397,500	2.5 M to 2.4 M (-4.10 %)
Sep 20 2018	TPND	BioPharmX Corp	Tierney David S	CEO	Buy	P	0.20	100,000	20,250	7,500,000	7.4 M to 7.5 M (+1.35 %)
Sep 13 2018	TPND	BioPharmX Corp	Tierney David S	CEO	Option Exercise	A	0.22	7,400,000	1,628,000	7,400,000
Sep 11 2018	TPND	BioPharmX Corp	Krammer Anja B	President	Option Exercise	A	0.20	1,042,000	208,400	1,042,000
Mar 09 2018	TPND	BioPharmX Corp	Vivo Capital VIII, LLC	10% Owner	Sell	S	0.36	2,000,000	720,000	16,128,515	18.1 M to 16.1 M (-11.03 %)
Jan 31 2018	TPND	BioPharmX Corp	Vivo Capital VIII, LLC	10% Owner	Option Exercise	C	0.00	1,515	0	0
Jan 31 2018	TPND	BioPharmX Corp	Vivo Capital VIII, LLC	10% Owner	Buy	C	0.00	4,328,571	0	18,128,515	13.8 M to 18.1 M (+31.37 %)
Jan 09 2018	TPND	BioPharmX Corp	Krammer Anja B	President	Option Exercise	A	0.11	1,960,000	215,600	1,960,000
Dec 22 2017	TPND	BioPharmX Corp	Morlock Stephen	Director	Option Exercise	A	0.20	205,000	41,000	205,000
Dec 22 2017	TPND	BioPharmX Corp	Morlock Stephen	Director	Option Exercise	A	0.10	450,000	45,000	450,000
Dec 22 2017	TPND	BioPharmX Corp	Krammer Anja B	President	Option Exercise	A	0.10	940,000	94,000	940,000
Dec 22 2017	TPND	BioPharmX Corp	Kitchener Gregory David	Chief Financial Off ...	Option Exercise	A	0.20	414,000	82,800	414,000
Dec 22 2017	TPND	BioPharmX Corp	Kitchener Gregory David	Chief Financial Off ...	Option Exercise	A	0.10	900,000	90,000	900,000
Dec 22 2017	TPND	BioPharmX Corp	Hubbard Michael	Director	Option Exercise	A	0.20	205,000	41,000	205,000
Dec 22 2017	TPND	BioPharmX Corp	Hubbard Michael	Director	Option Exercise	A	0.10	450,000	45,000	450,000
Dec 22 2017	TPND	BioPharmX Corp	Chan Kin Foong	EVP of R&D	Option Exercise	A	0.20	414,000	82,800	414,000
Dec 22 2017	TPND	BioPharmX Corp	Chan Kin Foong	EVP of R&D	Option Exercise	A	0.10	900,000	90,000	900,000
Nov 27 2017	TPND	BioPharmX Corp	Morlock Stephen	Director	Option Exercise	P	0.25	330,000	82,500	330,000
Nov 27 2017	TPND	BioPharmX Corp	Morlock Stephen	Director	Option Exercise	P	0.20	330,000	66,000	330,000
Nov 27 2017	TPND	BioPharmX Corp	Morlock Stephen	Director	Buy	P	0.15	330,000	49,500	873,956	544 K to 874 K (+60.67 %)
Nov 13 2017	TPND	BioPharmX Corp	Vivo Capital VIII, LLC	10% Owner	Sell	S	0.20	296,394	59,279	13,799,944	14.1 M to 13.8 M (-2.10 %)
Aug 03 2017	TPND	BioPharmX Corp	FRANKLIN RESOURCES INC	10% Owner	Buy	P	0.34	250,000	84,300	9,749,615	9.5 M to 9.7 M (+2.63 %)
May 01 2017	TPND	BioPharmX Corp	Vivo Capital Fund VIII, L.P.	10% Owner	Option Exercise	P	0.90	641,026	576,923	641,026
May 01 2017	TPND	BioPharmX Corp	Vivo Capital Fund VIII, L.P.	10% Owner	Buy	P	0.78	1,282,052	1,000,001	14,096,338	12.8 M to 14.1 M (+10.00 %)
Apr 19 2017	TPND	BioPharmX Corp	Chan Kin Foong	EVP of R&D	Option Exercise	A	0.74	435,000	321,900	435,000
Apr 19 2017	TPND	BioPharmX Corp	Kitchener Gregory David	Chief Financial Off ...	Option Exercise	A	0.74	290,000	214,600	290,000
Apr 19 2017	TPND	BioPharmX Corp	Krammer Anja B	President	Option Exercise	A	0.74	1,060,000	784,400	1,060,000
Apr 19 2017	TPND	BioPharmX Corp	VONTZ CHARLES GREGORY	Director	Option Exercise	A	0.74	200,000	148,000	200,000
Apr 19 2017	TPND	BioPharmX Corp	Morlock Stephen	Director	Option Exercise	A	0.74	200,000	148,000	200,000
Apr 19 2017	TPND	BioPharmX Corp	Hubbard Michael	Director	Option Exercise	A	0.74	200,000	148,000	200,000
Jan 20 2017	TPND	BioPharmX Corp	VONTZ CHARLES GREGORY	Director	Option Exercise	A	0.45	60,000	27,000	60,000
Jan 20 2017	TPND	BioPharmX Corp	VONTZ CHARLES GREGORY	Director	Option Exercise	A	0.45	65,000	29,250	65,000
Dec 12 2016	TPND	BioPharmX Corp	Chan Kin Foong	EVP of R&D	Option Exercise	A	0.42	150,000	63,000	150,000
Dec 12 2016	TPND	BioPharmX Corp	Kitchener Gregory David	Chief Financial Off ...	Option Exercise	A	0.42	175,000	73,500	175,000
Dec 12 2016	TPND	BioPharmX Corp	Krammer Anja B	President	Option Exercise	A	0.42	400,000	168,000	400,000
Dec 12 2016	TPND	BioPharmX Corp	Morlock Stephen	Director	Option Exercise	A	0.42	150,000	63,000	150,000
Dec 12 2016	TPND	BioPharmX Corp	Hubbard Michael	Director	Option Exercise	A	0.42	150,000	63,000	150,000
Nov 30 2016	TPND	BioPharmX Corp	FRANKLIN RESOURCES INC	10% Owner	Option Exercise	P	0.35	4,375,000	1,531,250	4,375,000
Nov 30 2016	TPND	BioPharmX Corp	FRANKLIN RESOURCES INC	10% Owner	Buy	P	0.00	4,375,000	0	9,499,615	5.1 M to 9.5 M (+85.37 %)
Nov 29 2016	TPND	BioPharmX Corp	Morlock Stephen	Director	Option Exercise	A	0.35	321,428	112,500	496,428
Nov 29 2016	TPND	BioPharmX Corp	Morlock Stephen	Director	Grant	A	0.35	428,571	150,000	543,956	115.4 K to 544 K (+371.43 %)
Aug 16 2016	TPND	BioPharmX Corp	Morlock Stephen	Director	Grant	A	0.65	115,385	75,000	115,385	0 to 115.4 K
Aug 16 2016	TPND	BioPharmX Corp	FRANKLIN RESOURCES INC	10% Owner	Buy	P	0.65	484,615	315,000	5,124,615	4.6 M to 5.1 M (+10.44 %)
Jul 25 2016	TPND	BioPharmX Corp	Chan Kin Foong	EVP of R&D	Option Exercise	A	0.62	170,000	105,400	225,000
Jul 25 2016	TPND	BioPharmX Corp	Kitchener Gregory David	Chief Financial off ...	Option Exercise	A	0.62	110,000	68,200	400,000
Jul 25 2016	TPND	BioPharmX Corp	Krammer Anja B	President	Option Exercise	A	0.62	360,000	223,200	465,000
Jul 25 2016	TPND	BioPharmX Corp	Barbarosh Craig A.	Director	Option Exercise	A	0.62	65,000	40,300	175,000
Jul 25 2016	TPND	BioPharmX Corp	Morlock Stephen	Director	Option Exercise	A	0.62	65,000	40,300	175,000
Jul 25 2016	TPND	BioPharmX Corp	Hubbard Michael	Director	Option Exercise	A	0.62	65,000	40,300	195,000
Jul 06 2016	TPND	BioPharmX Corp	Kitchener Gregory David	Chief Financial off ...	Option Exercise	A	0.65	55,000	35,750	290,000
Jul 06 2016	TPND	BioPharmX Corp	Chan Kin Foong	EVP of R&D	Option Exercise	A	0.65	55,000	35,750	55,000
Jul 06 2016	TPND	BioPharmX Corp	Krammer Anja B	President	Option Exercise	A	0.65	105,000	68,250	105,000
Jun 14 2016	TPND	BioPharmX Corp	Morlock Stephen	Director	Option Exercise	A	0.76	60,000	45,600	110,000
Jun 14 2016	TPND	BioPharmX Corp	Barbarosh Craig A.	Director	Option Exercise	A	0.76	60,000	45,600	110,000
Jun 14 2016	TPND	BioPharmX Corp	Hubbard Michael	Director	Option Exercise	A	0.76	80,000	60,800	130,000
Mar 31 2016	TPND	BioPharmX Corp	FRANKLIN RESOURCES INC	10% Owner	Option Exercise	P	1.20	270,000	324,000	270,000
Mar 31 2016	TPND	BioPharmX Corp	FRANKLIN RESOURCES INC	10% Owner	Buy	P	1.20	540,000	648,000	4,640,000	4.1 M to 4.6 M (+13.17 %)
Jan 27 2016	TPND	BioPharmX Corp	Barbarosh Craig A.	Director	Option Exercise	A	1.55	50,000	77,500	50,000
Jan 15 2016	TPND	BioPharmX Corp	Morlock Stephen	Director	Buy	P	1.53	5,500	8,415	251,071	245.6 K to 251.1 K (+2.24 %)
Jan 15 2016	TPND	BioPharmX Corp	Morlock Stephen	Director	Buy	P	1.52	6,500	9,880	245,571	239.1 K to 245.6 K (+2.72 %)
Jan 12 2016	TPND	BioPharmX Corp	Morlock Stephen	Director	Buy	P	1.63	3,000	4,890	239,071	236.1 K to 239.1 K (+1.27 %)
Jan 12 2016	TPND	BioPharmX Corp	Morlock Stephen	Director	Buy	P	1.43	3,000	4,290	236,071	233.1 K to 236.1 K (+1.29 %)
Jan 11 2016	TPND	BioPharmX Corp	Morlock Stephen	Director	Buy	P	1.47	5,000	7,350	233,071	228.1 K to 233.1 K (+2.19 %)
Oct 15 2015	TPND	BioPharmX Corp	Morlock Stephen	Director	Buy	P	1.23	3,000	3,690	228,071	225.1 K to 228.1 K (+1.33 %)
Oct 15 2015	TPND	BioPharmX Corp	Morlock Stephen	Director	Buy	P	1.25	2,000	2,500	225,071	223.1 K to 225.1 K (+0.90 %)
Oct 13 2015	TPND	BioPharmX Corp	Morlock Stephen	Director	Buy	P	1.19	2,000	2,380	223,071	221.1 K to 223.1 K (+0.90 %)
Oct 13 2015	TPND	BioPharmX Corp	Morlock Stephen	Director	Buy	P	1.26	1,000	1,260	221,071	220.1 K to 221.1 K (+0.45 %)
Aug 12 2015	TPND	BioPharmX Corp	Kitchener Gregory David	CFO	Option Exercise	A	1.67	235,000	392,450	235,000
Jul 02 2015	TPND	BioPharmX Corp	Morlock Stephen	Director	Grant	A	0.00	1,364	0	220,071	218.7 K to 220.1 K (+0.62 %)
Jun 29 2015	TPND	BioPharmX Corp	Morlock Stephen	Director	Option Exercise	C	0.00	13,514	0	0
Jun 29 2015	TPND	BioPharmX Corp	Morlock Stephen	Director	Buy	C	0.00	13,839	0	218,707	204.9 K to 218.7 K (+6.76 %)
May 01 2015	TPND	BioPharmX Corp	Morlock Stephen	Director	Option Exercise	A	3.00	50,000	150,000	50,000
May 01 2015	TPND	BioPharmX Corp	Hubbard Michael	Director	Option Exercise	A	3.00	50,000	150,000	50,000

Page: 1